14th Clinical Trials on Alzheimer's Disease Conference (CTAD 2021) – Late-Breaking Readout Roundtable 6 Top-line Results from the GAIN Trial: A Phase 2/3 Study of Atuzaginstat in Mild to Moderate Alzheimer’s Disease

November 11, 2021 at 11:35 AM EST

The live stream of the CTAD 2021 presentation has ended.

Supporting Materials